Physician profile
Keysha Bryer
NPI 1013671189
$2,306.76
in general payments reported to CMS, 2019-2025
15 companies · $549 in 2025
The $549 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,274 · 2024: $484 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,306.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $384.90 | 2023-2025 | Strensiq |
| Teva Pharmaceuticals USA, INC. | $364.22 | 2023-2025 | Austedo Xr, Uzedy |
| Janssen Pharmaceuticals, INC | $258.73 | 2024-2025 | Spravato |
| Madrigal Pharmaceuticals | $146.52 | 2025 | Rezdiffra |
| Sumitomo Pharma America, INC. | $143.57 | 2023 | Gemtesa |
| Abbvie INC. | $124.99 | 2023 | |
| Dermavant Sciences, INC. | $124.99 | 2023 | Vtama |
| Gilead Sciences, INC. | $124.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2024 | Jardiance |
| Sanofi Pasteur INC. | $124.97 | 2023 | |
| Dexcom, INC. | $121.32 | 2023 | Dexcom G7 Gss (161) |
| Itamar Medical INC | $98.22 | 2023 | Watchpatone |
| Neurelis, INC. | $93.43 | 2023 | Valtoco |
| Exact Sciences Corporation | $51.68 | 2023 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $19.24 | 2023 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keysha Bryer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.